Le Lézard
Classified in: Mining industry, Covid-19 virus
Subject: OBI

Galiano Gold Announces Passing of COO


VANCOUVER, BC, July 31, 2020 /CNW/ - Galiano Gold Inc. ("Galiano" or the "Company") (TSX: GAU) (NYSE: GAU) (formerly Asanko Gold Inc.) announces with a heavy heart the passing of the Company's Chief Operating Officer, Mr. Josephat Zvaipa, as a result of complications associated with a COVID-19 infection. The entire Galiano Gold and Asanko Gold Ghana family mourns this loss and we extend our deepest sympathies to Joe's family.

Mr. Zvaipa joined the group in 2014 and had been the Managing Director of Asanko Gold Ghana Limited from 2015 to mid-2019 during the time that the Asanko Gold Mine was financed, built and commissioned.

He played a pivotal role in making the Asanko Gold Mine a reality we are all proud of today.

Joe moved to Johannesburg to assume the role of Chief Operating Officer of Galiano Gold in 2019. His booming voice, passion and larger than life personality will be sorely missed.

The Asanko Gold Mine Joint Venture will continue to be managed by the Executive Vice-President and Managing Director of Asanko Gold Ghana, Mr. Fred Attakumah. 

About Galiano Gold Inc.
Galiano is focused on creating a sustainable business capable of long-term value creation for its stakeholders through organic production growth, exploration and disciplined deployment of its financial resources. The company currently operates and manages the Asanko Gold Mine, located in Ghana, West Africa which is jointly owned with Gold Fields Ltd. The Company is strongly committed to the highest standards for environmental management, social responsibility, and health and safety for its employees and neighbouring communities. For more information, please visit www.galianogold.com.

Neither Toronto Stock Exchange nor the Investment Industry Regulatory Organization of Canada accepts responsibility for the adequacy or accuracy of this release.

SOURCE Galiano Gold Inc.


These press releases may also interest you

at 01:20
Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in thedevelopment oftherapeutics for age-related diseases, today annouces that it will change the ratio...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The economic turmoil triggered by the COVID-19 pandemic has led to a sharp decrease in the number of self-employed individuals in the United States, with a 22% reduction...

18 avr 2024
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of QuidelOrtho Corporation between February 18, 2022 and April 1, 2024, both dates inclusive (the "Class...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: